0001752724-21-047856.txt : 20210309
0001752724-21-047856.hdr.sgml : 20210309
20210309163204
ACCESSION NUMBER: 0001752724-21-047856
CONFORMED SUBMISSION TYPE: N-CEN
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20201231
FILED AS OF DATE: 20210309
DATE AS OF CHANGE: 20210309
EFFECTIVENESS DATE: 20210309
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mirae Asset Discovery Funds
CENTRAL INDEX KEY: 0001489215
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0430
FILING VALUES:
FORM TYPE: N-CEN
SEC ACT: 1940 Act
SEC FILE NUMBER: 811-22406
FILM NUMBER: 21726291
BUSINESS ADDRESS:
STREET 1: 625 MADISON AVENUE
STREET 2: 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 212-205-8300
MAIL ADDRESS:
STREET 1: 625 MADISON AVENUE
STREET 2: 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
0001489215
S000065276
Mirae Asset Emerging Markets Great Consumer VIT Fund
C000211317
Class I Shares
N-CEN
1
primary_doc.xml
X0303
N-CEN
LIVE
0001489215
XXXXXXXX
811-22406
true
false
false
N-1A
S000065276
true
Mirae Asset Discovery Funds
811-22406
0001489215
549300UD1B8SO7KOZC53
625 Madison Avenue
3rd Floor
New York
10022
US-NY
US
212-205-8300
Mirae Asset Global Investments (USA) LLC
625 Madison Avenue
3rd Floor
New York
10022
888-335-3417
Investment manager for Mirae Asset Discovery Funds
Citi Fund Services Ohio, Inc.
4400 Easton Commons
Suite 200
Columbus
43219
614-470-8471
Administrator and Fund Accounting Agent for Mirae Asset Discovery Funds
FIS Investor Services, LLC
4249 Easton Way
Suite 400
Columbus
43219
614-337-6684
Transfer Agent for Mirae Asset Discovery Funds
Citibank, N.A.
111 Wall Street
New York
10005
646-248-6738
Custodian for Mirae Asset Discovery Funds
N
N
N-1A
3
Y
Laurence Smith
N/A
N
Keith M. Schappert
N/A
N
Joon Hyuk Heo
N/A
Y
Enrique R. Arzac
N/A
N
Thomas N. Calabria
002780599
625 Madison Avenue
3rd Floor
New York
10022
XXXXXX
N
N
N
N
N
N
N
Funds Distributor, LLC
8-20518
000007174
N/A
Y
N
Cohen & Company, Ltd.
925
N/A
N
N
N
N
N
N
N
Mirae Asset Emerging Markets Great Consumer VIT Fund
S000065276
5493006C1BO3JIVWGO60
N
1
0
0
N/A
N
N
Y
N
N/A
N/A
N/A
Rule 17e-1 (17 CFR 270.17e-1)
Y
Y
Y
N
Mirae Asset Global Investments (USA) LLC
801-69439
000147548
549300UD1B8SO7KOZC53
N
Mirae Asset Global Investments (Hong Kong) Ltd.
801-71088
000152807
213800TUUUQUT8GHZ555
Y
HK
N
FIS Investor Services LLC
084-06522
N/A
N
N
N
Bloomberg L.P.
549300B56MD0ZC402L06
N
ICE Data Services
5493000NQ9LYLDBCTL34
N
Virtu Financial, Inc.
5493001OPW2K42CH3884
N
PricingDirect Inc.
549300WIC0TOJ7N7GD54
N
Y
Citibank, N.A.
E57ODZWZ7FF32TWEFA76
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
Citibank, N.A.
E57ODZWZ7FF32TWEFA76
N
N
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
N
N
Citi Fund Services Ohio, Inc.
549300OX9HIV34JOX333
N
N
N
Mirae Asset Securities (Hong Kong) Ltd.
N/A
000152807
213800TUUUQUT8GHZ555
HK
438.90
HSBC
008-41562
000019585
CYYGQCGNHMHPSMRL3R97
395.54
MORGAN STANLEY
008-15869
000008209
9R7GPTSO7KV3UQJZQ078
386.80
CLSA LTD.
008-69166
000165533
213800M2DXATWY7JMS07
247.92
MIRAE SECURITIES
N/A
000152807
213800TUUUQUT8GHZ555
HK
438.90
CITIGROUP
008-08177
000007059
MBNUM2BPBDO7JBLYG310
767.38
GOLDMAN SACHS & CO. LLC
008-00129
000000361
FOR8UP27PHTHYVLBNG30
301.00
JP MORGAN CHASE
008-35008
000000079
ZBUT11V806EZRVTWT807
482.17
DAIWA CAPITAL MARKETS AMERICA INC.
008-12242
000001576
M67H5PRC0NQKM73ZAS82
216.18
CHINA MERCHANTS SECURITIES HK
N/A
N/A
549300VCT4IH7HC2NQ22
HK
361.02
UBS WARBURG
008-22651
000007654
T6FIZBDPKLYJKFCRVK44
654.48
5769.89
GOLDMAN SACHS & CO. LLC
008-00129
000000361
FOR8UP27PHTHYVLBNG30
125.00
CITIGROUP
008-08177
000007059
MBNUM2BPBDO7JBLYG310
494108.52
MORGAN STANLEY
008-15869
000008209
9R7GPTSO7KV3UQJZQ078
287.48
494521.00
Y
2768767.90
Uncommitted
15000000.00000000
N
N
N
N
false
false
true
false
false
false
INTERNAL CONTROL RPT
2
Mirae_N-CEN_Letter.txt
MIRAE N-CEN LETTER
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders and Board of Trustees of
Mirae Asset Discovery Funds
In planning and performing our audit of the financial statements
of Mirae Asset Discovery Funds comprising Emerging Markets
Great Consumer VIT Fund (the 'Fund') as of and for the year
ended December 31, 2020, in accordance with the standards of the
Public Company Accounting Oversight Board (United States)
(PCAOB), we considered the Fund's internal control over
financial reporting, including controls over safeguarding
securities, as a basis for designing our auditing procedures for
the purpose of expressing our opinion on the financial
statements and to comply with the requirements of Form N-CEN,
but not for the purpose of expressing an opinion on the
effectiveness of the Fund's internal control over financial
reporting. Accordingly, we express no such opinion.
The management of the Fund is responsible for establishing and
maintaining effective internal control over financial
reporting. In fulfilling this responsibility, estimates and
judgments by management are required to assess the expected
benefits and related costs of controls. A fund's internal
control over financial reporting is a process designed to
provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements
for external purposes in accordance with generally accepted
accounting principles (GAAP). A fund's internal control over
financial reporting includes those policies and procedures that
(1) pertain to the maintenance of records that, in reasonable
detail, accurately and fairly reflect the transactions and
dispositions of the assets of the fund; (2) provide reasonable
assurance that transactions are recorded as necessary to permit
preparation of financial statements in accordance with GAAP, and
that receipts and expenditures of the fund are being made only
in accordance with authorizations of management and trustees of
the fund; and (3) provide reasonable assurance regarding
prevention or timely detection of unauthorized acquisition, use
or disposition of a fund's assets that could have a material
effect on the financial statements.
Because of its inherent limitations, internal control over
financial reporting may not prevent or detect misstatements.
Also, projections of any evaluation of effectiveness to future
periods are subject to the risk that controls may become
inadequate because of changes in conditions, or that the degree
of compliance with the policies or procedures may deteriorate.
A deficiency in internal control over financial reporting exists
when the design or operation of a control does not allow
management or employees, in the normal course of performing
their assigned functions, to prevent or detect misstatements on
a timely basis. A material weakness is a deficiency, or
combination of deficiencies, in internal control over financial
reporting, such that there is a reasonable possibility that a
material misstatement of the Fund's annual or interim financial
statements will not be prevented or detected on a timely basis.
Our consideration of the Fund's internal control over financial
reporting was for the limited purpose described in the first
paragraph and would not necessarily disclose all deficiencies in
internal control that might be material weaknesses under
standards established by the PCAOB. However, we noted no
deficiencies in the Fund's internal control over financial
reporting and its operation, including controls over
safeguarding securities, that we consider to be a material
weakness as defined above as of December 31, 2020.
This report is intended solely for the information and use of
management and the Board of Trustees of the Fund and the
Securities and Exchange Commission and is not intended to be and
should not be used by anyone other than these specified parties.
COHEN & COMPANY, LTD.
Cleveland, Ohio
February 25, 2021